Tag: life sciences
-
Synthetic DNA Company Raises $24M in Early Funds
A company with a technology it says is simpler and more like natural processes to produce synthetic DNA is raising $24 million in its first venture round.
-
Mobile App Studied to Measure Kidney Disease Anemia
A smartphone app designed to non-invasively estimate hemoglobin levels is being assessed for its ability to measure anemia in chronic kidney disease patients.
-
Nine Campuses Join Rural Food Research Fund
Nine universities in the U.S. are taking part in a program supporting research and entrepreneurs developing food and agricultural solutions in rural areas.
-
Gene Therapy Company Exploring DNA Circuit Technology
Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits.
-
Vaccine Stops Lyme Bacteria in Preclinical Test
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease.
-
Antibody Cocktail Prevents Covid-19 Disease Symptoms
A clinical trial shows two synthetic antibodies given together reduce the risk of symptomatic infections among household members of Covid-19 patients.
-
Arthritis Drug Unsuccessful for Covid-19 Hospital Patients
A clinical trial shows a drug designed to reduce inflammation in autoimmune disease patients does not clearly help patients hospitalized with Covid-19 disease.
-
NIH Trial Testing mRNA Vaccine Allergic Effects
A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response.
-
Small Biz Grant Funds Wrist Fracture Adhesive
A company developing a biocompatible material to aid bone healing will test the substance on treating simulated wrist fractures in large animals.
-
Infectious Disease Biotech Raises $100M in Venture Funds
A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round.